<?xml version="1.0" encoding="UTF-8"?>
<p>The baseline seroprevalence was estimated using samples from 2,853 participants who authorized a blood sample collection at enrollment. The overall baseline dengue seroprevalence in the cohort was 70.28% (95% CI 68.6%â€“72%) indicating that most of the population had already been exposed to at least one dengue infection (
 <xref ref-type="fig" rid="pntd.0006847.g002">Fig 2</xref>).
</p>
